Energetic Metabolism in the Treatment of Prostate Cancer: Effects of P-MAPA Immunomodulator

Favoritar este trabalho

The American Cancer Society estimates that 161.360 new cases of Prostate Cancer will be diagnosed in the United States of America (USA) in 2017. Faced with such alarming data, research into new terapeutic options is necessary, and the P-MAPA immunomodulator opens a new perspective for the combat of this type of cancer. Therefore, the aim of this study is to characterize the molecular effects of P-MAPA immunotherapy in Prostate Cancer treatment involving cellular energy metabolism.